Drug Profile
GLI 8545
Latest Information Update: 04 Dec 2006
Price :
$50
*
At a glance
- Originator Galileo Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Renal failure
Most Recent Events
- 07 May 2003 Galileo Laboratories is now called Galileo Pharmaceuticals
- 03 Jan 2003 Clinical trials in Renal failure in USA (PO)